About
Marvell Technology Group Ltd (NASDAQ:MRVL) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
Marvell Announces Acquisition of Polariton Technologies, Advancing Optical Performance Scaling to 3.2T and Beyond
Apr 17 2026
Marvel Biosciences Announces Closing of Convertible Debenture Offering
Apr 16 2026
Marvel Biosciences Identifies Liquid Formulations for Neurodevelopmental Disorders
Apr 13 2026
Marvel Biosciences Announces an Amendment to the Conversion Price for Marvel's Proposed Convertible Debenture Offering
Apr 8 2026
Marvel Biosciences Announces Proposed Convertible Debenture Offering
Financials
Revenue
$8.19 B
Market Cap
$93.66 B
P/E Ratio
34.89
EPS
3.07
Dividend Yield
0.22%
Google Übersetzer